{"name":"Inspirna, Inc.","slug":"inspirna-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNaENfUWlfb3NjZGlvWjNfQUhONkV6aXZ6R01qVEE5SEtWWm03SEQ5ai1tMUk4bms4U0g0Z3hiLTVLeTd0Rm1xVDhnU2R0YmpaNEdlaHBud3FkNDdPcllpbXc4ZVJ3Zk1OZUVQOXhteEV1dF9tYURxNERjT29MXzltb2ZUaXRTTkNhVWdmQ25nQ05EMEJDZEVZ?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Leading Companies Reinforcing Their Presence in the Anal Fissure Treatment Market - openPR.com","headline":"Leading Companies Reinforcing Their Presence in the Anal Fissure Treatment Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPSlFhcVdwaFlONm5LenM3akJpY2hmc04zT3hMeWFVMm50ZTBMTWNZNlFWRFBUOUdJZ010blhQNkpKR1gzd2NwN0lDOXFRQlFQVmZZSW82aDRiYU94a3VaZDkxWWsxTWJGUEJlNnJWa1pGV2FEZkFLX3QyVWJJSDQ2ajgxZnVQY25wZnloZ3RBOVR4RGhSZ1REYjhHWGhzeTlmVjFmbEQ5b1ZSTktKQzltVDM0bHdBNm1DSEM2S1VSbEl0a0QybjUzZE5laFF2YTFqSkZNYlVrdXBKQm9lVjlZTTZiSDMwa3YzMUgwaHAxeV82LVNKZTFoZUI5ZG1NbThqUlE5bEFBUWJ6Rm5XcVV5Q2VWNl9NREdCN2lycUhOU2otUEh6NDBmSERtS3VPaENoMnI3M0tKRmxmTjg?oc=5","date":"2025-05-13","type":"trial","source":"GlobeNewswire","summary":"Metastatic Colorectal Cancer Clinical Trial Pipeline - GlobeNewswire","headline":"Metastatic Colorectal Cancer Clinical Trial Pipeline","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxOOEloNzBMUVo2VDlxYlpXM2NsZWh0Zmgyb0dZc2dWaXJNUm9adUtqNmdKaWVIWGZnbFJrdWE3bHhZeFlMYkZfc1lpb0N3TXVRQXExTUJaQUZFWFdOTlJOQjhsYkpBM2piWEhJazBwRlpKaUs2YzN0LWFyLW1OUFFSREpRM1IzbklTVkU0Y2RSUHB6TTdnNG0zUGZMVHNnWHhhVlZMRXdwNklETXVwY0tSQ2J3am82VmpRQ2dRX2d6WHh0cGg0TGR4ZEVTb1JGYXNKX2I4S0xBcDFsSWRla1JmaXEzdHdGTVlPcXVXSXJWekRLdUNzQk1VS1YzMVVQVjE2eFZLQjB6Y2JhWFZTbWZXN2l5OFRlOEYxZ3o2ZHFHMkJuMUdZM0ltX3NJRTJSNWVZTWUybThENGFlSWh4ZWc?oc=5","date":"2025-04-23","type":"pipeline","source":"PR Newswire","summary":"Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakthrough Therapies Gain Traction | DelveInsight - PR Newswire","headline":"Metastatic Colorectal Cancer Market Poised for Expansion Across the 7MM During the Forecast Period (2025-2034) as Breakt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOeTFIY0NDOWY2T3hDWWt3RHV6bXdzbXlSMUszQ3ZqendBeF9iZ3BNanBLMVZpYl90aG1iZFFpYkU5cEw0eVoyMWJ3bjVTQm5TQWg4U0E4dmZ5ZWotVzZ4NjBQcGpMVGxUQ0s1eWNNN2RCWmdRUUxtWUFGTVhfLV9QMkE2S1hIUmVzcGZxb0htVjU0ZGwwa3kyNnlwa2E1TWZrSlZwS1F4QTY?oc=5","date":"2025-04-01","type":"pipeline","source":"Fierce Biotech","summary":"Cancer biotech Inspirna winding down as its odyssey in microRNA comes to an end - Fierce Biotech","headline":"Cancer biotech Inspirna winding down as its odyssey in microRNA comes to an end","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPeHV2bDVvM1pOa2hWeWdZYVBHS1J5c0luS05RQ2x5eTUyTkJMQnlPU0txNjBmNnZnS1FxVV9zbGlmN3NObzhqMGFXVUNjTUVYMkdQek1vckpNVFZVZVFmNHE2LWEzdVRRUTk5bjd3TFU0SG5qZGJ6RU9fNExWdEtDcU41WC1GZU9UQlZTWG9ub3pFZEVJZDMxVWJUTzJObzc4UDdET3pkMA?oc=5","date":"2024-01-04","type":"deal","source":"Contract Pharma","summary":"Merck KGaA, Inspirna Partner on Colorectal Cancer Portfolio - Contract Pharma","headline":"Merck KGaA, Inspirna Partner on Colorectal Cancer Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE45YnlGNkYzaTVvbjNxWEt5N1ZUaDZHaHpiOGhILXJlX3hFYjAtU2dmVFdFajBkdnBOSlpybzExME5iMGRGcy15VlRuR1JGYVdoYmF1MXNnMTVoNjk0OWpYdGxseURIc0g4S0RHR3BUZWZ2NXpNemlQYU1kXzNGdw?oc=5","date":"2024-01-04","type":"pipeline","source":"Merck Group","summary":"Agreement with Inspirna for Ompenaclid - Merck Group","headline":"Agreement with Inspirna for Ompenaclid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNRWtCRnI3QXFEWkFCVWNWVnZuZjhpcVhqa08wZFM0aXAxZWlSY3BZZ0R6UXcxTng2M2VqNkoxV0NnY3BaakdxVHlDQkRUd1A2dE9LVV90SmxJVmtUTmVkSmZjdUVrYWZWczV6SE1BTzJMS2JybHNwLVZDNVp0WEt4YVQyMjhTYl9mem9ITw?oc=5","date":"2024-01-04","type":"pipeline","source":"pharmaphorum","summary":"Merck bets on Inspirna’s colorectal cancer drug ompenaclid - pharmaphorum","headline":"Merck bets on Inspirna’s colorectal cancer drug ompenaclid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPNUNDR2FZdU13TjJ2SDFOcWVzQklMNUhsVFdUVWxxR3FsMS1FR3Vkc2FRQWVQZjluZzdpZWlaQ0Q1RVdKYVRhdjNPQndOM1ZEQTlmdmpzWHhYMGo4U1JuMU52eFJLT2tSTEp4QXJVRVVTSTF3VXlXWjNaVmVNQ1JDQU9yNTVHaExVU3dVVFJFTWFNT0hLdGNodDVvaHNuNjhhZFhja21GVDU5OWozRTNvUzlPWVJOMFUxeWhEeVFWallkd1ZHODVxaXBUUGQ2RGdvUWRNdXdaUmFVcW1YX0FSejBxTGszOGZFM1N6M2dtNXR6ellVR1E?oc=5","date":"2024-01-04","type":"deal","source":"Business Wire","summary":"Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid (RGX-202) - Business Wire","headline":"Inspirna Partners with Merck KGaA, Darmstadt, Germany, to Accelerate Global Development of Ompenaclid (RGX-202)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOMnR2VTFXQ3RhRlpjd1pMXzBUVlBiT2pwMmJXd2VjMWhPWTlPb0dkQ0hMdy1Ka0xIaUpsM3JaRFJ6d2tycWpxX2VFSGFydU1DXzQ3b3lCelRNNzd1M0xOWHk1OGZiSkJTRTNtOHhWLXFhUWpLSDN0WG9ZVndTSEtjVGZSRXlrSC0xeGFhZGtqd0o1YjU5c0dsb18yNUhLNGw2a3hGZlNjYWhYMDRPcTJScmVJSkNZZkFCWTZFNUNpSWhKbWRVR0VvR2lZNjkzbW9meUJ4VGpSQ2Ewd1Z6MWVUQTRIT2ZnbWl1VHVuSEp2dEFidm12RU5SUEp6Y0ZxRUJXQWpkNzM5QVFaUkVzWk8tdWtzckM?oc=5","date":"2021-09-30","type":"pipeline","source":"Business Wire","summary":"RGENIX Announces Company Name Change to Inspirna and Expands Board of Directors with Appointment of Pharma Veteran Dieter Weinand - Business Wire","headline":"RGENIX Announces Company Name Change to Inspirna and Expands Board of Directors with Appointment of Pharma Veteran Diete","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}